Health

Caliway Announced EMA Orphan Drug Designation Granted to CBL-514 for Dercum's Disease Treatment

- CBL-514 is the first and only drug to receive EMA Orphan Drug Designation for Dercum's disease treatment. - CBL-514 received both FDA Orphan Drug Designation and Fast Track designation for Dercum's disease treatment earlier this year. - CBL-514 Phase 2 study for Dercum's disease showed that it c...

2024-11-13 13:36 1118

DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution

DKSH Healthcare and Euris have launched "ConnectPlus", a complete Customer Relationship Management (CRM) and Multi-Channel Engagement (MCE) platform set to transform healthcare distribution across APAC. This data-driven, agile solution enhances efficiency by providing a comprehensive view of heal...

2024-11-13 09:00 9632

SpaceGut Debuts AI-Driven Gut Health Testing in Malaysia, Offering Personalized Wellness Solutions

KUALA LUMPUR, Malaysia, Nov. 13, 2024 /PRNewswire/ -- SpaceGut,  part of SOL Partnership Sdn Bhd, is proud to introduce Malaysia's first AI-powered at-home Gut Microbiome Test Kit. Officially launched on12 November 2024 at Cookhouse's Artisan's Playground, the innovative k...

2024-11-13 09:00 1834

Health Enthusiasts and Experts Unite at the USANA Health Symposium

MANILA, Philippines, Nov. 13, 2024 /PRNewswire/ -- USANA Philippines, in its unwavering commitment to promote health and wellness, recently conducted its second health symposium held at the SMX Convention Center in Pasay City, bringing together a distinguished lineup of experts in health, wellnes...

2024-11-13 08:57 1487

The Shaw Prize Award Presentation Ceremony 2024: 21 Years of Celebrating Excellence in Scientific Achievements

HONG KONG, Nov. 13, 2024 /PRNewswire/ -- The Shaw Prize presented its awards to five Shaw Laureates today at the 2024 Award Presentation Ceremony, held in the Hong Kong Convention and Exhibition Centre. Approximately 600 guests from various sectors participated in the event.

2024-11-13 02:50 1634

Zymo Research Fights Back Against Qiagen's Lawsuit, Asserts Antitrust Violations and Attempts to Stifle Innovation

IRVINE, Calif., Nov. 13, 2024 /PRNewswire/ -- Zymo Research Corporation (Zymo Research), a leader in innovative life science solutions, announced today that it has filed claims in the United District Court for the Central District of California against Qiagen GmbH (Qiagen) alleging that Qiagen has...

2024-11-13 00:54 1155

The Sigourney Award-2024 Recipients Honored For Outstanding Work Advancing Psychoanalytic Principles Globally

Four Recipients' Work From Israel, Sweden, Canada and South Africa Earns The Sigourney Award-2024 SEATTLE, Nov. 12, 2024 /PRNewswire/ -- The Sigourney Award Trust annually recognizes outstanding work that advances psychoanalytic thought and principles throughout the world.Robin A. Deutsch, PhD a...

2024-11-12 22:20 1143

Hospital Sant Pau and Huawei join forces to accelerate digital transformation in healthcare

BARCELONA, Spain, Nov. 12, 2024 /PRNewswire/ -- Industry Leaders from Hospital de Sant Pau and Huawei today outlined a vision of how digital technology can make hospitals more efficient and improve patients' lives. The speakers shared their though...

2024-11-12 22:04 1124

Metabolon Services Used in Pioneering Multiomic Research on Brain Metabolism and Neurodegenerative Disorders

Ground-breaking investigation leverages Metabolon's Global Discovery Panel for metabolite genome-wide association study (MGWAS) for cerebrospinal fluid (CSF) and brain metabolite levels as they pertain to neurodegenerative disorders MORRISVILLE, N.C., Nov. 12, 2024 /PRNewswire/ -- Metabolon, Inc....

2024-11-12 22:00 1131

Ascletis Completes Enrollment of Phase III Trial of ASC40 (Denifanstat) Once-Daily Oral Tablet for Treatment of Acne

-Phase III trial enrolled a total of 480 patients with moderate to severe acne -Topline results expected in the second quarter 2025 HANGZHOU, China, Nov. 12, 2024 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces completion of enrollment of 480 patients for Phase III c...

2024-11-12 19:30 1348

Gan & Lee Pharmaceuticals Announced Positive Phase 1 Results for Its Oral GLP-1 Receptor Agonist GZR18 Tablet in Healthy Participants, Demonstrating 4.16% Weight Reduction in Two Weeks

* After two weeks of treatment, GZR18 tablets resulted in an average weight reduction of up to 4.16%, with continued weight loss observed even after discontinuation. * The pharmacokinetic profile supports a once-daily oral dosing regimen for GZR18 tablets. * The safety and tolerability of G...

2024-11-12 19:00 1154

deCODE genetics/Amgen: New Study Explores the Role of BMI in Disease Risk

REYKJAVIK, Iceland, Nov. 12, 2024 /PRNewswire/ -- New study from deCODE genetics/Amgen highlights the importance of BMI in pathogenesis of disease, suggesting that reducing BMI alone could lower the risk of several diseases.   Kari Stefansson and Gudmundur Einarsson, scientists at deCODE genetic...

2024-11-12 18:00 1053

World's First Patent Acquired for Animal Supplement "Pinfenon" (S) (R)

- Patent Covers Invention of Treatment Drug and Prophylactic Drug for Lowering Cardiac Disorder Markers in Dogs as Well as Their Manufacturing Methods - TOKYO, Nov. 12, 2024 /PRNewswire/ -- Scarecrow Incorporated, based in Tokyo's Shibuya Ward, is pleased to announce that it has acquired the worl...

2024-11-12 14:00 1185

Fosun International Wins "The Asset ESG Corporate Awards 2024 - Platinum Award" and "Best Initiative in Social Responsibility" from The Asset

HONG KONG, Nov. 12, 2024 /PRNewswire/ -- On the evening of 7 November 2024, The Asset, a renowned Asian financial magazine, held "The Asset ESG Corporate Awards 2024" awards ceremony at the Four Seasons Hotel Singapore. Fosun International Limited ("Fosun International" or the "Company") (HKEX st...

2024-11-12 10:35 1379

PathogenDx Applauded by Frost & Sullivan for Enabling Early and Precise UTI Diagnosis with Its Microarray Detection Platform

PathogenDx's Microarray Detection Platform is the fastest and most cost-effective test for UTI detection withhigher throughput for efficient and accurate diagnosis. SAN ANTONIO, Nov. 11, 2024 /PRNewswire/ -- Frost & Sullivan recently assessed the multiplexed urinary tract infection detection ind...

2024-11-11 23:00 1190

Economist Impact's 4th edition Future of Health Asia to empower healthcare stakeholders by building strategies for a sustainable healthcare system, and igniting investment for an inclusive and healthier future

Members of the media are invited to register here . SINGAPORE, Nov. 11, 2024 /PRNewswire/ -- The 4th edition Future of Health A...

2024-11-11 20:56 1763

Diabetes Singapore and GSK Join Forces to Spotlight Increased Risk of Viral Infections for People with Diabetes

* Diabetes Singapore and GSK aim to enhance awareness and improve lives affected by diabetes through educational talks and activities on World Diabetes Day * 1 in 3 people will get shingles in their lifetime; People with diabetes are 38% more likely to contract shingles[1] * People with dia...

2024-11-11 20:47 1244

ObesityWeek®️ 2024 | Gan & Lee Pharmaceuticals Orally Presents Phase 2b Clinical Data for GZR18 Injection in Chinese Overweight and Obese Adults

* Obese or overweight participants receiving bi-weekly doses of 12 mg, 18 mg, 24 mg, 48 mg, and once-weekly dose of 24 mg GZR18 for 30 weeks achieved mean percent changes in body weight from baseline of -11.15%, -13.22%, -14.25%, -17.29%, and -17.78%, respectively, with the placebo group at -0....

2024-11-11 19:36 1168

HKBN x INDICAID Introduce Hong Kong's First At-Home Health Test Monthly Subscription Service

HKBN further expands footprint in medical services HONG KONG, Nov. 11, 2024 /PRNewswire/ -- Hong Kong Broadband Network Limited ("HKBN") has partnered with renowned at-home health test brand, INDICAID, to provide HKBN customers with an innovative healthcare subscription service featuring a varie...

2024-11-11 16:06 1221

Nordic Bioscience receives Letter of Support from the FDA for the CPa9-HNE biomarker in inflammatory bowel diseases

HERLEV, Denmark, Nov. 11, 2024 /PRNewswire/ -- Nordic Bioscience, a leading biomarker company, announced that its CPa9-HNE biomarker assay received a Letter of Support (LoS) from the U.S. Food and Drug Administration (FDA). CPa9-...

2024-11-11 15:00 1087
1234567 ... 580